Quantitative MR Biomarkers for Sarcoma Treatment

Completed · Not applicable

Conditions studied: Soft Tissue Tumors

In brief

To determine if MRI imaging can be used to accurately determine if a sarcoma is responding to the type of chemotherapy being used.

Key facts

Study ID

NCT01017978

Run by

University of Michigan

People needed

11

Starts

2009-07-01

Expected to finish

2012-04-01

Last updated by the study team

2015-12-04

Who can join

Age: 3 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Biopsy proven primary bone or soft tissue tumor
• No previous treatment for this malignancy
• Will be given chemotherapy before having surgery or radiation on the tumor.
• Are able to undergo a MRI examination
• If your tumor measures at least 1/2 inch in length.

You may not qualify if…

• Younger than 3 yrs. of age or need general anesthesia(sedation that puts you to sleep) to have a MRI performed.
• History of Renal Failure
• Are not able to have a MRI performed for any reason such as you have a pacemaker or other implanted device that may malfunction or move because of the magnetic field inside the MRI room and scanner.
• Have any history of an allergic reaction to gadolinium based contrast agents (a medication injected in a vein that helps create clearer MRI images.

Where it is running

• University of Michigan Health System — Ann Arbor, Michigan, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.